2024 SPEAKERS

 

 

Celine Adessi, Global Head, Clinical Sciences, Early Development Oncology, Roche

Ana Sofia Afonso, Director, Pharmacoepidemiology, Global Patient Safety, ELI LILLY

Ana Sofia Afonso | Director, Pharmacoepidemiology, Global Patient Safety | ELI LILLY » speaking at Drug Safety EU

Amit Aggarwal, Executive Director, Medical Affairs & Strategic Partnerships, ABPI

Amit Aggarwal | Executive Director, Medical Affairs & Strategic Partnerships | ABPI » speaking at Drug Safety EU

Omar Aimer, Executive Committee member of ISoP; Founder of InnoVigilance, Innovigilance

Omar Aimer | Executive Committee member of ISoP; Founder of InnoVigilance | Innovigilance » speaking at Drug Safety EU

Alison Allen, Director, Global Pharmacovigilance (PV) Quality Assurance, Alnylam Pharmaceuticals

Ibrahim Altamawy, Medical Affairs & Compliance Regional Head (MENA), SAJA Pharmaceuticals

Ibrahim Altamawy | Medical Affairs & Compliance Regional Head (MENA) | SAJA Pharmaceuticals » speaking at Drug Safety EU

Justyna Amelio, Director, Global Epidemiology, AbbVie

Justyna Amelio | Director, Global Epidemiology | AbbVie » speaking at Drug Safety EU

Anand Ananthakrishnan, Senior Director, Drug Safety and Pharmacovigilance, Blueprint Medicines

Kate Anteyi, Director, Global Safety Physician, Moderna Therapeutics

Kate Anteyi | Director, Global Safety Physician | Moderna Therapeutics » speaking at Drug Safety EU

Wasim Anwar, Vice President, Deputy QPPV, Novo Nordisk A/S

Wasim Anwar | Vice President, Deputy QPPV | Novo Nordisk A/S » speaking at Drug Safety EU

Ludovic Apoux, Director, Global Lead, Signal Detection, Haleon

Ludovic Apoux | Director, Global Lead, Signal Detection | Haleon » speaking at Drug Safety EU

Julia Appelskog, Senior Director, EU QPPV, Global Vaccine Safety, novavax

Felix Arellano, Senior Vice President, Global Head of Safety and Risk Management, Roche

Felix Arellano | Senior Vice President, Global Head of Safety and Risk Management | Roche » speaking at Drug Safety EU

Simon Ashworth, Head of Pharmacovigilance and Medical Safety, Ono Pharmaceutical Co., Ltd

Simon Ashworth | Head of Pharmacovigilance and Medical Safety | Ono Pharmaceutical Co., Ltd » speaking at Drug Safety EU

Ercem Atillasoy, Chief Regulatory and Safety Officer, Jazz Pharmaceuticals

Ercem Atillasoy | Chief Regulatory and Safety Officer | Jazz Pharmaceuticals » speaking at Drug Safety EU

Mina G Awad, Pharmacovigilance Senior Manager and QPPV, Middle East, Kyowa Kirin International

Mina G Awad | Pharmacovigilance Senior Manager and QPPV, Middle East | Kyowa Kirin International » speaking at Drug Safety EU

Tea Babic, Director, Head of PV Audits and Inspections, Deputy Head PV Compliance, Teva Pharmaceuticals

Tea Babic | Director, Head of PV Audits and Inspections, Deputy Head PV Compliance | Teva Pharmaceuticals » speaking at Drug Safety EU

Jamal Baig, Director, Pharmacovigilance, Multi Country Safety Head, Sanofi

Jamal Baig | Director, Pharmacovigilance, Multi Country Safety Head | Sanofi » speaking at Drug Safety EU

Amina Baljic, Senior Director, Head, PV Operations and PV Excellence, Grunenthal

Amina Baljic | Senior Director, Head, PV Operations and PV Excellence | Grunenthal » speaking at Drug Safety EU

Alexandru Barbarosie, EU/UK QPPV, Global Safety Lead, Amryt Pharma

Alexandru Barbarosie | EU/UK QPPV, Global Safety Lead | Amryt Pharma » speaking at Drug Safety EU

Erika Barbarosie, Associate Director, Compliance, Gilead Sciences

Erika Barbarosie | Associate Director, Compliance | Gilead Sciences » speaking at Drug Safety EU

Judy Barretto, Senior Global Process Director, Signal Management, Roche

Judy Barretto | Senior Global Process Director, Signal Management | Roche » speaking at Drug Safety EU

Eniko Barta-Kondas, Head, Global PV Operations, Gedeon Richter PLC

Eniko Barta-Kondas | Head, Global PV Operations | Gedeon Richter PLC » speaking at Drug Safety EU

Sylvie Bartus, Senior Director, Clinical Safety Global, Clinical Affairs, Surgical Structural Heart, Edwards Lifesciences

Sylvie Bartus | Senior Director, Clinical Safety Global, Clinical Affairs, Surgical Structural Heart | Edwards Lifesciences » speaking at Drug Safety EU

Erica Bavol, Senior Director, Head of Safety Operations, Compliance and Systems, Corcept

Erica Bavol | Senior Director, Head of Safety Operations, Compliance and Systems | Corcept » speaking at Drug Safety EU

Arvind Bellur, Executive Director, Head, PV Innovation and Transformation, CSL behring

Arvind Bellur | Executive Director, Head, PV Innovation and Transformation | CSL behring » speaking at Drug Safety EU

Begum Benli Peker, Director, Head of Patient Safety Netherlands & EU Hub Lead, Bristol Myers Squibb

Begum Benli Peker | Director, Head of Patient Safety Netherlands & EU Hub Lead | Bristol Myers Squibb » speaking at Drug Safety EU

Ricarda Berg, Associate Director, Head of Pharmacovigilance, DACH Region, Biogen

Majken Berghuis, Director, Pharmacovigilance, International Operations, Novo Nordisk

Majken Berghuis | Director, Pharmacovigilance, International Operations | Novo Nordisk » speaking at Drug Safety EU

Fatima Bhayat, Independent PV Expert

Fatima Bhayat |  | Independent PV Expert » speaking at Drug Safety EU

Raj Bhogal, Senior Director, R&D Business Strategy & Operations, Jazz Pharmaceuticals

Raj Bhogal | Senior Director, R&D Business Strategy & Operations | Jazz Pharmaceuticals » speaking at Drug Safety EU

Kapil Bhutada, Senior Director, Quality and Compliance, Inozyme Pharma

Kapil Bhutada | Senior Director, Quality and Compliance | Inozyme Pharma » speaking at Drug Safety EU

Mariette Boerstoel Streefland, Senior Vice President, Worldwide Patient Safety Officer, Bristol Myers Squibb

Mariette Boerstoel Streefland | Senior Vice President, Worldwide Patient Safety Officer | Bristol Myers Squibb » speaking at Drug Safety EU

Laura Paola Boga, Senior Director, Head of Global Pharmacovigilance, UK & EU QPPV, Dompé farmaceutici SpA

Laura Paola Boga | Senior Director, Head of Global Pharmacovigilance, UK & EU QPPV | Dompé farmaceutici SpA » speaking at Drug Safety EU

Chris Bone, Pharmacovigilance Scientist, Biogen

Chris Bone | Pharmacovigilance Scientist | Biogen » speaking at Drug Safety EU

Emma Boulton, Director, Safety Operations, Mundipharma

Emma Boulton | Director, Safety Operations | Mundipharma » speaking at Drug Safety EU

Ronald Boumans, Independent Medical Devices Expert, EU Medical Devices Expert

Ronald Boumans | Independent Medical Devices Expert | EU Medical Devices Expert » speaking at Drug Safety EU

Barbara Bovy, Director, Head, Auditing and Compliance EarlyDevSol, Innovation & Data, UCB

Siva Kumar Buddha, Global Pharmacovigilance Physician, Senior Manager, Teva Pharmaceuticals

Siva Kumar Buddha | Global Pharmacovigilance Physician, Senior Manager | Teva Pharmaceuticals » speaking at Drug Safety EU

Sean Burke, Senior Director, Regional Lead, International Pharmacovigilance, MSD

Gloria Bustos Busto, Senior Director, Head of Pharmacovigilance, EMEA & APAC / Global Patient Safety, Baxter Healthcare

Gloria Bustos Busto | Senior Director, Head of Pharmacovigilance, EMEA & APAC / Global Patient Safety | Baxter Healthcare » speaking at Drug Safety EU

Mattia Calissano, Director, Head of Pharmacovigilance, Orchard Therapeutics

Pilar Carrero, Vice President, Global Safety, LEO Pharma

Patrick Caubel, Chief Safety Officer, Pfizer

Akhilesh Chamediya, Global Medical Director, Patient Safety Lead, AstraZeneca & Alexion

Akhilesh Chamediya | Global Medical Director, Patient Safety Lead | AstraZeneca & Alexion » speaking at Drug Safety EU

Mijal Chavda, Senior Director, Global Head of GxP Inspections & GVP Quality, Kyowa Kirin International

Mijal Chavda | Senior Director, Global Head of GxP Inspections & GVP Quality | Kyowa Kirin International » speaking at Drug Safety EU

David Chonzi, Independent Pharma Physician, Independent PV Expert

David Chonzi | Independent Pharma Physician | Independent PV Expert » speaking at Drug Safety EU

Rishi Chopra, Executive Director, Global Head of Pharmacovigilance Regions, CSL

Rishi Chopra | Executive Director, Global Head of Pharmacovigilance Regions | CSL » speaking at Drug Safety EU

Mugdha Chopra, Co-Founder and Director, AWINSA Life Sciences

Mugdha Chopra | Co-Founder and Director | AWINSA Life Sciences » speaking at Drug Safety EU

Irina Maria Ciubotaru, Vice President, Head of Global Drug Safety and Pharmacovigilance, EU & UK QPPV, ITM Isotope Technologies Munich SE

Irina Maria Ciubotaru | Vice President, Head of Global Drug Safety and Pharmacovigilance, EU & UK QPPV | ITM Isotope Technologies Munich SE » speaking at Drug Safety EU

Jan Cleerbout, Deputy QPPV, Johnson & Johnson Innovative Medicine

Jan Cleerbout | Deputy QPPV | Johnson & Johnson Innovative Medicine » speaking at Drug Safety EU

Marco Colombati, PV Operations Manager, ITALFARMACO S.P.A.

Marco Colombati | PV Operations Manager | ITALFARMACO S.P.A. » speaking at Drug Safety EU

Lynne Comiskey, Divestment Coordination Lead, Sanofi

Lynne Comiskey | Divestment Coordination Lead | Sanofi » speaking at Drug Safety EU

Elena Cucu, Deputy EU QPPV, AbbVie

Elena Cucu | Deputy EU QPPV | AbbVie » speaking at Drug Safety EU

Juan Daccach, Vice President, Global Product Safety, Merz Aesthetics

Mark Daniels, Director, Safety Physician, Jazz Pharmaceuticals

Mark Daniels | Director, Safety Physician | Jazz Pharmaceuticals » speaking at Drug Safety EU

Margherita D'Antuono, EU-UK QPPV, Piramal Critical Care

Margherita D'Antuono | EU-UK QPPV | Piramal Critical Care » speaking at Drug Safety EU

Michelle Motta Dardeno, Vice President, Head, Global Patient Safety, Aurinia

Michelle Motta Dardeno | Vice President, Head, Global Patient Safety | Aurinia » speaking at Drug Safety EU

Ms Magda Daudin, Director, Head of PV Operations and Compliance, Idorsia

Ms Magda Daudin | Director, Head of PV Operations and Compliance | Idorsia » speaking at Drug Safety EU

Abiola David, Senior Director, Global Process Owner, ICSR Management, PV Operations, GSK

Abiola David | Senior Director, Global Process Owner, ICSR Management, PV Operations | GSK » speaking at Drug Safety EU

Elena Davison, Executive Director, Global Pharmacovigilance Informatics, Sunovion Pharmaceuticals

Elena Davison | Executive Director, Global Pharmacovigilance Informatics | Sunovion Pharmaceuticals » speaking at Drug Safety EU

Ton de Boer, Chairman, CBG-MEB Medicines Evaluation Board

Ton de Boer | Chairman | CBG-MEB Medicines Evaluation Board » speaking at Drug Safety EU

Fabio De Gregorio, Vice President, Head Of Drug Safety Europe, Shionogi BV

Fabio De Gregorio | Vice President, Head Of Drug Safety Europe | Shionogi BV » speaking at Drug Safety EU

Peter De Veene, Associate Vice President, Global QPPV, MSD

Peter De Veene | Associate Vice President, Global QPPV | MSD » speaking at Drug Safety EU

Frédérique Delannois, Executive Director, Safety Evaluation & Risk Management Head, Global Safety, GSK

Frédérique Delannois | Executive Director, Safety Evaluation & Risk Management Head, Global Safety | GSK » speaking at Drug Safety EU

Sunita Dhar, Executive Medical Group Director, Clinical Safety, Genentech

Sunita Dhar | Executive Medical Group Director, Clinical Safety | Genentech » speaking at Drug Safety EU

Priyadarshani Dharia, Director, Global Safety Epidemiology, Real World Evidence, Moderna Therapeutics

Priyadarshani Dharia | Director, Global Safety Epidemiology, Real World Evidence | Moderna Therapeutics » speaking at Drug Safety EU

Daniela Di Cosmo, Senior Safety Advisor, Global Safety, Ferring Pharmaceuticals

Daniela Di Cosmo | Senior Safety Advisor, Global Safety | Ferring Pharmaceuticals » speaking at Drug Safety EU

Robert Di Giovanni, Senior Global Patient Safety Lead, Novartis

Robert Di Giovanni | Senior Global Patient Safety Lead | Novartis » speaking at Drug Safety EU

Elisabetta Di Martino, Director, GCP, GVP & GLP, Quality Assurance, Orchard Therapeutics

Elisabetta Di Martino | Director, GCP, GVP & GLP, Quality Assurance | Orchard Therapeutics » speaking at Drug Safety EU

Shaantanu Donde, Senior Medical Director, Head of Portfolio Management Team, Clinical Development & Medical Affairs, Viatris

Shaantanu Donde | Senior Medical Director, Head of Portfolio Management Team, Clinical Development & Medical Affairs | Viatris » speaking at Drug Safety EU

Markus Drumm, Head of Global Patient Safety Regions, Merck Healthcare KGaA

Markus Drumm | Head of Global Patient Safety Regions | Merck Healthcare KGaA » speaking at Drug Safety EU

Dr. Joan D'souza, Independent PV Expert

Dr. Joan D'souza |  | Independent PV Expert » speaking at Drug Safety EU

Nancy Dubois, Senior Director, Head of Global Patient Safety, US Region, EMD Serono

Nancy Dubois | Senior Director, Head of Global Patient Safety, US Region | EMD Serono » speaking at Drug Safety EU

Melanie Dullemond, PV Compliance Head, Medical and PV Quality, Sanofi

Melanie Dullemond | PV Compliance Head, Medical and PV Quality | Sanofi » speaking at Drug Safety EU

Marjan Dzeparoski, RA and PV Manager, Bionika Pharmaceuticals

Marjan Dzeparoski | RA and PV Manager | Bionika Pharmaceuticals » speaking at Drug Safety EU

Philip Eichorn, Global Head of Drug Safety, Chiesi

Philip Eichorn | Global Head of Drug Safety | Chiesi » speaking at Drug Safety EU

Dineke Eikelboom, Associate Director, Medical Safety, Pharmacovigilance, Astellas Pharma

Dineke Eikelboom | Associate Director, Medical Safety, Pharmacovigilance | Astellas Pharma » speaking at Drug Safety EU

James Eldridge, Director, Global Safety Surveillance, Y-mAbs

Maha Lakshmi Elluri, Global Safety Director, EEA/UK QPPV, Indivior Pharmaceuticals

Maha Lakshmi Elluri | Global Safety Director, EEA/UK QPPV | Indivior Pharmaceuticals » speaking at Drug Safety EU

Maritess Esguerra, Senior PV Process Director, Genentech

Maritess Esguerra | Senior PV Process Director | Genentech » speaking at Drug Safety EU

Sebastian Fischer, Regulatory Strategy Principal, TUV SUD Product Service GmbH

John Fitzpatrick, Senior Pharmacovigilance Manager, ProPharma

John Fitzpatrick | Senior Pharmacovigilance Manager | ProPharma » speaking at Drug Safety EU

Garry Flounders, Global Pharmacovigilance Operations Lead, Biosimilars, Biogen

Garry Flounders | Global Pharmacovigilance Operations Lead, Biosimilars | Biogen » speaking at Drug Safety EU

Suzanne Foncin, Senior Director, Head of Safety Analysis and Writing, UCB

Suzanne Foncin | Senior Director, Head of Safety Analysis and Writing | UCB » speaking at Drug Safety EU

Sarah Freestone, Vice President, Head of Pharmacovigilance and Device Safety, UCB Pharma

Sarah Freestone | Vice President, Head of Pharmacovigilance and Device Safety | UCB Pharma » speaking at Drug Safety EU

Antonella Fretta, Senior Director, Aggregate Reporting Team Lead, Pfizer

Antonella Fretta | Senior Director, Aggregate Reporting Team Lead | Pfizer » speaking at Drug Safety EU

Ilana Frishman, Senior Director, Pharmacovigilance & Drug Safety, Compugen

Ilana Frishman | Senior Director, Pharmacovigilance & Drug Safety | Compugen » speaking at Drug Safety EU

Tsambika Fuchs, Team Lead PV Intelligence and Performance Management, Merck Healthcare KGaA

Tsambika Fuchs | Team Lead PV Intelligence and Performance Management | Merck Healthcare KGaA » speaking at Drug Safety EU

Giovanni Furlan, Director, Worldwide Safety Site Lead, Pfizer

Giovanni Furlan | Director, Worldwide Safety Site Lead | Pfizer » speaking at Drug Safety EU

Stewart Geary, Global Safety Officer, Eisai

Serban Ghiorghiu, Chief Safety Officer, AstraZeneca

Serban Ghiorghiu | Chief Safety Officer | AstraZeneca » speaking at Drug Safety EU

Jenny Griffiths, Senior Principal Associate, Medicines Quality Organisation, Eli Lilly and Company

Jenny Griffiths | Senior Principal Associate, Medicines Quality Organisation | Eli Lilly and Company » speaking at Drug Safety EU

Ilaria Grisoni, Executive Director, Head of EU & International Pharmacovigilance, QPPV Office and EEA QPPV, Jazz Pharmaceuticals

Ilaria Grisoni | Executive Director, Head of EU & International Pharmacovigilance, QPPV Office and EEA QPPV | Jazz Pharmaceuticals » speaking at Drug Safety EU

Katarzyna Gruchala, Director, PV Operations Global Submissions, Moderna

Katarzyna Gruchala | Director, PV Operations Global Submissions | Moderna » speaking at Drug Safety EU

Uwe Gudat, Chief Medical Officer, Biocon Biologics

Uwe Gudat | Chief Medical Officer | Biocon Biologics » speaking at Drug Safety EU

Sibel Guerler, Senior Director, Head of Innovation, Partnerships and Process Optimisation, WorldWide Patient Safety, Bristol Myers Squibb

Sibel Guerler | Senior Director, Head of Innovation, Partnerships and Process Optimisation, WorldWide Patient Safety | Bristol Myers Squibb » speaking at Drug Safety EU

Israel Gutierrez, Chief Medical Officer, TLR Therapeutics

Israel Gutierrez | Chief Medical Officer | TLR Therapeutics » speaking at Drug Safety EU

Tanuja Halady, Senior Medical Director, Head of Global Patient Safety, Oncology Group III, Merck

Tanuja Halady | Senior Medical Director, Head of Global Patient Safety, Oncology Group III | Merck » speaking at Drug Safety EU

Diane Halle, Senior Manager, Pharmacovigilance Quality Assurance, Alnylam Pharmaceuticals

Diane Halle | Senior Manager, Pharmacovigilance Quality Assurance | Alnylam Pharmaceuticals » speaking at Drug Safety EU

Matthieu Hammer, Director, Head Data Processing and Quality, Merck

Matthieu Hammer | Director, Head Data Processing and Quality | Merck » speaking at Drug Safety EU

Lucy Hampshire, Associate Vice President, Head, Medicines Quality Organisation International, Eli Lilly And Company

John Hart, Director, EEA & UK QPPV, Samsung Bioepis NL B.V

John Hart | Director, EEA & UK QPPV | Samsung Bioepis NL B.V » speaking at Drug Safety EU

Fabian Heisig, Senior Vice President, Head Global Drug Safety & QPPV, Grunenthal

Fabian Heisig | Senior Vice President, Head Global Drug Safety & QPPV | Grunenthal » speaking at Drug Safety EU

Cristina Hentea, Director, Safety Surveillance and Risk Management, Viatris

Cristina Hentea | Director, Safety Surveillance and Risk Management | Viatris » speaking at Drug Safety EU

Peter Hjelmstrom, Director, Uppsala Monitoring Centre

Juri Hodisch, Head, Drug Safety, QPPV, AOP Health

Juri Hodisch | Head, Drug Safety, QPPV | AOP Health » speaking at Drug Safety EU

Nawal Jebbar, Lead, Safety and Pharmacovigilance, EMEA & EU QPPV, Amylyx Pharmaceuticals

Conny Johansson, Alliance Management Lead, Roche

Conny Johansson | Alliance Management Lead | Roche » speaking at Drug Safety EU

Philip Jones, Senior Director, Disease Area Cluster Lead, Inflammation & Immunology, Pfizer

Philip Jones | Senior Director, Disease Area Cluster Lead, Inflammation & Immunology | Pfizer » speaking at Drug Safety EU

Justin Joubert, Senior Director, Acquisitions, PV Agreements & Contract Liason, GSK

Justin Joubert | Senior Director, Acquisitions, PV Agreements & Contract Liason | GSK » speaking at Drug Safety EU

Juhaeri Juhaeri, Vice President & Global Head, Epidemiology and Benefit-Risk, Sanofi

Avinash Kakade, Senior Vice President, Global Head of Pharmacovigilance, Dr. Reddy's Laboratories

Avinash Kakade | Senior Vice President, Global Head of Pharmacovigilance | Dr. Reddy's Laboratories » speaking at Drug Safety EU

Achilleas Kalogirou, Lead, Office of Safety Operations, AbbVie

Achilleas Kalogirou | Lead, Office of Safety Operations | AbbVie » speaking at Drug Safety EU

ELENA KELLER, Director, PV, RA, Quality and Medical Operations, Local QPPV, Ipsen Pharma GmbH

ELENA KELLER | Director, PV, RA, Quality and Medical Operations, Local QPPV | Ipsen Pharma GmbH » speaking at Drug Safety EU

Ranjana Khanna, Global Director, GVP, QA, R&D Quality, BeiGene

Ranjana Khanna | Global Director, GVP, QA, R&D Quality | BeiGene » speaking at Drug Safety EU

Ben Kitchens, Associate Director, Medical Devices, Diagnostics Lead, Otsuka Pharmaceutical Companies (U.S.)

Ben Kitchens | Associate Director, Medical Devices, Diagnostics Lead | Otsuka Pharmaceutical Companies (U.S.) » speaking at Drug Safety EU

Kristin Knalstad, Director, Risk Management, Patient Safety, AstraZeneca

Kristin Knalstad | Director, Risk Management, Patient Safety | AstraZeneca » speaking at Drug Safety EU

Peter Kohut, Director, Pharmacovigilance, Alvotech

Mohammed Ali Kotal, Global Head, Medical Safety, Sandoz International GmbH

Smruti Kothari, Associate Director, PV QA, Jazz Pharmaceuticals

Smruti Kothari | Associate Director, PV QA | Jazz Pharmaceuticals » speaking at Drug Safety EU

Monika Kowalska, Director, Global Case Management, Moderna

Monika Kowalska | Director, Global Case Management | Moderna » speaking at Drug Safety EU

Marcin Kruk, Senior Director, Drug Safety Unit Regional Head, Europe, Africa & Middle East, Pfizer

Marcin Kruk | Senior Director, Drug Safety Unit Regional Head, Europe, Africa & Middle East | Pfizer » speaking at Drug Safety EU

Leith Kwaan, QPPV, National Bioproducts Institute NPC

Leith Kwaan | QPPV | National Bioproducts Institute NPC » speaking at Drug Safety EU

Wally Landsberg, Vice President, Global Head Medical Safety, Kyowa Kirin, Inc.

Wally Landsberg | Vice President, Global Head Medical Safety | Kyowa Kirin, Inc. » speaking at Drug Safety EU

Finn Larsen, Head, Technology and Data Management, Sandoz Patient Safety

Finn Larsen | Head, Technology and Data Management | Sandoz Patient Safety » speaking at Drug Safety EU

Lisa Lawrence-Miyasaki, Vice President, Head of Pharmacovigilance, Alumis

Lisa Lawrence-Miyasaki | Vice President, Head of Pharmacovigilance | Alumis » speaking at Drug Safety EU

Jost Leemhuis, Safety Science Partner and Global Business Lead, Roche

Jost Leemhuis | Safety Science Partner and Global Business Lead | Roche » speaking at Drug Safety EU

Claudia Lehmann, Vice President, Head, Patient Safety & Pharmacovigilance Operations, Boehringer Ingelheim International

Claudia Lehmann | Vice President, Head, Patient Safety & Pharmacovigilance Operations | Boehringer Ingelheim International » speaking at Drug Safety EU

Petra Lerner-Hiller, Deputy QPPV, PV Quality and QPPV Relations Lead, Merck

Petra Lerner-Hiller | Deputy QPPV, PV Quality and QPPV Relations Lead | Merck » speaking at Drug Safety EU

Alexander Liede, Senior Director, Global Epidemiology, AbbVie

Alexander Liede | Senior Director, Global Epidemiology | AbbVie » speaking at Drug Safety EU

Fabio Lievano, Vice President, Safety Science, AbbVie

Fabio Lievano | Vice President, Safety Science | AbbVie » speaking at Drug Safety EU

Luiz Lima, Vice President, Head of Neuroscience, Global Patient Safety, Ipsen

Luiz Lima | Vice President, Head of Neuroscience, Global Patient Safety | Ipsen » speaking at Drug Safety EU

Rita Lobatto, Vice President Pharmacovigilance & QPPV, Pharming Group

Rita Lobatto | Vice President Pharmacovigilance & QPPV | Pharming Group » speaking at Drug Safety EU

Emanuel Lohrmann, Director, PV Therapeutic Area Lead, Cardio Renal, Otsuka Pharmaceuticals

Emanuel Lohrmann | Director, PV Therapeutic Area Lead, Cardio Renal | Otsuka Pharmaceuticals » speaking at Drug Safety EU

Karsten Lollike, Corporate Vice President, QPPV, Novo Nordisk

Karsten Lollike | Corporate Vice President, QPPV | Novo Nordisk » speaking at Drug Safety EU

Raj Long, Deputy Director, Integrated Development, Global Health, Bill and Melinda Gates Foundation

Raj Long | Deputy Director, Integrated Development, Global Health | Bill and Melinda Gates Foundation » speaking at Drug Safety EU

Claire Longman, Expert Pharmacovigilance Inspector, MHRA

Claire Longman | Expert Pharmacovigilance Inspector | MHRA » speaking at Drug Safety EU

Asif Mahmood, Vice President, Medical Safety & Pharmacovigilance, AskBio

Asif Mahmood | Vice President, Medical Safety & Pharmacovigilance | AskBio » speaking at Drug Safety EU

Valentina Mancini, Senior Director, Pharmacovigilance, EU & UK QPPV, Shionogi & TransCelerate

Valentina Mancini | Senior Director, Pharmacovigilance, EU & UK QPPV | Shionogi & TransCelerate » speaking at Drug Safety EU

Monika Manske, Associate Director, Lead Quality Management and Deputy EEA QPPV, Viatris

Monika Manske | Associate Director, Lead Quality Management and Deputy EEA QPPV | Viatris » speaking at Drug Safety EU

Marcin Marciniak, Senior Director, Global Safety and PV Expert WHC, Gedeon Richter Switzerland

Marcin Marciniak | Senior Director, Global Safety and PV Expert WHC | Gedeon Richter Switzerland » speaking at Drug Safety EU

Jessica Mårlind Würtele, Director, Patient Safety Excellence, AstraZeneca

Jessica Mårlind Würtele | Director, Patient Safety Excellence | AstraZeneca » speaking at Drug Safety EU

Miriam Marotti, Senior Medical Director, Patient Safety Oncology, AstraZeneca

Miriam Marotti | Senior Medical Director, Patient Safety Oncology | AstraZeneca » speaking at Drug Safety EU

Robert Massouh, Head, Risk Management and Benefit-Risk Evaluation, GSK

Robert Massouh | Head, Risk Management and Benefit-Risk Evaluation | GSK » speaking at Drug Safety EU

Asa Mattsson, Senior Director, Patient Safety Risk Management, Process & Implementation, AstraZeneca

Asa Mattsson | Senior Director, Patient Safety Risk Management, Process & Implementation | AstraZeneca » speaking at Drug Safety EU

Jorgen Matz, Global Head, Pharmacovigilance & Clinical Quality, Insud Pharma

Richard Mayer, Senior Principal Engineer, Head of Medical Safety R&D, Johnson and Johnson

Richard Mayer | Senior Principal Engineer, Head of Medical Safety R&D | Johnson and Johnson » speaking at Drug Safety EU

Sanjeev Miglani, Founder and Director, AWINSA Life Sciences

Andrew Moore, Director, PV Operations and Compliance, Takeda

Andrew Moore | Director, PV Operations and Compliance | Takeda » speaking at Drug Safety EU

Marianne Mounir, Senior Global System Auditor, Bayer

Céline Muffang, Associate Director, Medical Safety & Pharmacovigilance, AskBio

Céline Muffang | Associate Director, Medical Safety & Pharmacovigilance | AskBio » speaking at Drug Safety EU

Sutirtha Mukhopadhyay, Senior Associate Director, Senior Patient Safety Physician, Boehringer Ingelheim

Sutirtha Mukhopadhyay | Senior Associate Director, Senior Patient Safety Physician | Boehringer Ingelheim » speaking at Drug Safety EU

Jaylaxmi Nalawade, Director, Pharmacovigilance and REMS, Lupin

Jaylaxmi Nalawade | Director, Pharmacovigilance and REMS | Lupin » speaking at Drug Safety EU

Yvonne Nanciu, Country Head, Pharmacovigilance, Deputy EU QPPV, Bayer

Yvonne Nanciu | Country Head, Pharmacovigilance, Deputy EU QPPV | Bayer » speaking at Drug Safety EU

Dominic Nguyen-Van-Tam, Senior Pharmacovigilance Inspector, MHRA

Dominic Nguyen-Van-Tam | Senior Pharmacovigilance Inspector | MHRA » speaking at Drug Safety EU

Thomas Nirnberger, Chief Executive Officer, Biofi

Thomas Nirnberger | Chief Executive Officer | Biofi » speaking at Drug Safety EU

Minhaj Obeidullah, Head, Compliance and Risk Management, Novartis

Minhaj Obeidullah | Head, Compliance and Risk Management | Novartis » speaking at Drug Safety EU

Kieran O'Donnell, Director, Independent PV Expert

Adeniyi Olagunju, Senior Lecturer, University of Liverpool

Attila Oláh, Vice President, Head, Global Patient Safety, EU-QPPV, Gedeon Richter PLC

Attila Oláh | Vice President, Head, Global Patient Safety, EU-QPPV | Gedeon Richter PLC » speaking at Drug Safety EU

Tom Organ, Safety Science Director, Neuroscience TA, Global Patient Safety, Ipsen

Tom Organ | Safety Science Director, Neuroscience TA, Global Patient Safety | Ipsen » speaking at Drug Safety EU

Karine Palin, Eu2P Programme Manager, University of Bordeaux

Shaloo Pandhi, Global Head, Patient Safety, Sandoz

Shaloo Pandhi | Global Head, Patient Safety | Sandoz » speaking at Drug Safety EU

Laura Pasetti, Director, Aggregate Reporting Author, Pfizer

Laura Pasetti | Director, Aggregate Reporting Author | Pfizer » speaking at Drug Safety EU

George P. Patrinos, Professor, Department of Pharmacy & Adjunct Professor, Department of Genetics and Genomics, University of Patras & United Arab Emirates University

Meenal Patwardhan, Vice President, AbbVie

Meenal Patwardhan | Vice President | AbbVie » speaking at Drug Safety EU

Anna Pelnikevich, Director, Head of Benefit-Risk Management, Merck

Anna Pelnikevich | Director, Head of Benefit-Risk Management | Merck » speaking at Drug Safety EU

Claudia Pierleoni-Nielsen, Director, Global Safety Surveillance, LEO Pharma

Claudia Pierleoni-Nielsen | Director, Global Safety Surveillance | LEO Pharma » speaking at Drug Safety EU

Emmanuelle Pinès, Head of Safety Policy & Process Oversight, QPPV Office, Janssen

Marta Pujol, Senior Director, Patient Safety, AstraZeneca

Marta Pujol | Senior Director, Patient Safety | AstraZeneca » speaking at Drug Safety EU

Alex Qiu, Executive Director and Therapeutic Area Lead, Early Development and External Partnerships, bristol myers squibb

Alex Qiu | Executive Director and Therapeutic Area Lead, Early Development and External Partnerships | bristol myers squibb » speaking at Drug Safety EU

Anne Raison, Head of Quality and Medical Compliance Management, ROCHE SAS France

Anne Raison | Head of Quality and Medical Compliance Management | ROCHE SAS France » speaking at Drug Safety EU

Nibedita Rath, Scientific Director, Open Source Pharma Foundation

Nibedita Rath | Scientific Director | Open Source Pharma Foundation » speaking at Drug Safety EU

Maria Jose Reneses, Director, Deputy EU QPPV and Head of PSMF, Takeda

Maria Jose Reneses | Director, Deputy EU QPPV and Head of PSMF | Takeda » speaking at Drug Safety EU

Pav Rishiraj, Director, Head of Patient Safety & ABPI PV Expert Chair, Ipsen & ABPI

Pav Rishiraj | Director, Head of Patient Safety & ABPI PV Expert Chair | Ipsen & ABPI » speaking at Drug Safety EU

Nayanika Rivankar, Associate Director, Signal Management Strategy Lead, Merck Group

Nayanika Rivankar | Associate Director, Signal Management Strategy Lead | Merck Group » speaking at Drug Safety EU

Nathan Rivers, Associate Director, Medical Safety, Oncology, Jazz Pharmaceuticals

Nathan Rivers | Associate Director, Medical Safety, Oncology | Jazz Pharmaceuticals » speaking at Drug Safety EU

Kathy Roberts, Vice President, Global Phamacovigilance, Incyte Corp.

Kathy Roberts | Vice President, Global Phamacovigilance | Incyte Corp. » speaking at Drug Safety EU

Hans-Jörg Römming, Executive Director, Head of GPS Operations, Merck

Hans-Jörg Römming | Executive Director, Head of GPS Operations | Merck » speaking at Drug Safety EU

Hadir Rostom, Independent PV Expert - Lecturer, Modern Sciences And Arts University

Hadir Rostom | Independent PV Expert - Lecturer | Modern Sciences And Arts University » speaking at Drug Safety EU

Zina Sadeq, Director, Regional PV and Alliance Management, Deputy UK QPPV, Amicus Therapeutics

Zina Sadeq | Director, Regional PV and Alliance Management, Deputy UK QPPV | Amicus Therapeutics » speaking at Drug Safety EU

Kishore Saha, Chief Specialist, Lundbeck

Myriam Salem, Pharmacovigilance Manager, Health Canada

Myriam Salem | Pharmacovigilance Manager | Health Canada » speaking at Drug Safety EU

Teresa Saragoça, Director, Regulatory Affairs & Technical Manager, ITALFARMACO PT

Teresa Saragoça | Director, Regulatory Affairs & Technical Manager | ITALFARMACO PT » speaking at Drug Safety EU

Gemma Sayers, Senior Director, Head, Global Development Quality Management, Regeneron Pharmaceuticals

Yvonne Schäfer, Head of Patient Safety & Pharmacovigilance Systems Business Solutions, Boehringer Ingelheim International

Yvonne Schäfer | Head of Patient Safety & Pharmacovigilance Systems Business Solutions | Boehringer Ingelheim International » speaking at Drug Safety EU

Claudia Schaffer, Senior Director, Head of Case and Vendor Management, Merck

Rudi Scheerlinck, Safety Strategy Lead, Merck Healthcare Oncology

Olaf Schickling, Senior Director, Head of QPPV Office, BeiGene Germany GmbH

Reinhold Schilling, Head of Global Pharmacovigilance, EU QPPV, Wörwag Pharma

Nadine Schreiber, Head, Global Pharmacovigilance, medac GmbH

Nadine Schreiber | Head, Global Pharmacovigilance | medac GmbH » speaking at Drug Safety EU

Uwe Schühly, Senior Global Program Safety Team Lead, Cell & Gene Therapy, Novartis

Uwe Schühly | Senior Global Program Safety Team Lead, Cell & Gene Therapy | Novartis » speaking at Drug Safety EU

Carrie Scott, Head, Global Pharmacovigilance Compliance and Policy, AbbVie

Vipin Sethi, Head of Global Pharmacovigilance And Medical Affairs, Cadila Pharmaceuticals

Vipin Sethi | Head of Global Pharmacovigilance And Medical Affairs | Cadila Pharmaceuticals » speaking at Drug Safety EU

Riti Shah, Medical Director, Chiesi

Riti Shah | Medical Director | Chiesi » speaking at Drug Safety EU

Mason Shih, Vice President, Safety Science, BioMarin Pharmaceutical Inc.

Mason Shih | Vice President, Safety Science | BioMarin Pharmaceutical Inc. » speaking at Drug Safety EU

Ira Solomon, Chief Safety Officer, Innovation, Johnson & Johnson

Ira Solomon | Chief Safety Officer, Innovation | Johnson & Johnson » speaking at Drug Safety EU

John Solomon, Head of Pharmacovigilance, UK & Ireland, Sanofi

John Solomon | Head of Pharmacovigilance, UK & Ireland | Sanofi » speaking at Drug Safety EU

Anna Stahl, Deputy EU QPPV, UK and Australia, BeiGene

Anna Stahl | Deputy EU QPPV, UK and Australia | BeiGene » speaking at Drug Safety EU

Vivien Stettner, International PV Operational Excellence Associate Director, AbbVie

Vivien Stettner | International PV Operational Excellence Associate Director | AbbVie » speaking at Drug Safety EU

Mette Stie Kallesøe, Head of Pharmacovigilance, QPPV, Hansa Biopharma

Mette Stie Kallesøe | Head of Pharmacovigilance, QPPV | Hansa Biopharma » speaking at Drug Safety EU

Milos Stojkovic, Safety Process Director, Roche

Milos Stojkovic | Safety Process Director | Roche » speaking at Drug Safety EU

Ariane Stollenwerk, Director, Head of Central Europe & Asian Int. Markets, International PhV, UCB Pharma

Ariane Stollenwerk | Director, Head of Central Europe & Asian Int. Markets, International PhV | UCB Pharma » speaking at Drug Safety EU

Johanna Strandell, Director Patient Safety, Camurus AB

Johanna Strandell | Director Patient Safety | Camurus AB » speaking at Drug Safety EU

Marko Strott, Associate Director, Partnership Management, Global Patient Safety, Merck

Marko Strott | Associate Director, Partnership Management, Global Patient Safety | Merck » speaking at Drug Safety EU

Karthick Sukumaran, Director, Technology Enablement, Intelligent Safety Automation, Roche Products Ltd

Karthick Sukumaran | Director, Technology Enablement, Intelligent Safety Automation | Roche Products Ltd » speaking at Drug Safety EU

Jutta Syha, Independent PV Expert

Jutta Syha |  | Independent PV Expert » speaking at Drug Safety EU

Stéphanie Tcherny-Lessenot, Global Head, Benefit-Risk Evaluation, Sanofi

Stéphanie Tcherny-Lessenot | Global Head, Benefit-Risk Evaluation | Sanofi » speaking at Drug Safety EU

Tarak Thakker, Director, Head of Safety Systems and Analytics, BeiGene

Tarak Thakker | Director, Head of Safety Systems and Analytics | BeiGene » speaking at Drug Safety EU

Phil Tregunno, Deputy Director, Patient Safety Monitoring, Medicines & Healthcare products Regulatory Agency

Phil Tregunno | Deputy Director, Patient Safety Monitoring | Medicines & Healthcare products Regulatory Agency » speaking at Drug Safety EU

Marco Tuccori, Pharmacovigilance Manager, Coordinator & Co-Chair, University Hospital of Pisa, Tuscan Regional Centre of Pharmacovigilance & ISoP Scientific Board

Marco Tuccori | Pharmacovigilance Manager, Coordinator & Co-Chair | University Hospital of Pisa, Tuscan Regional Centre of Pharmacovigilance & ISoP Scientific Board » speaking at Drug Safety EU

Anastasia Ukhova, Global Medical Head, Digital Healthcare, Sanofi

Anastasia Ukhova | Global Medical Head, Digital Healthcare | Sanofi » speaking at Drug Safety EU

Vivienne van de Walle, Medical Director, P.T. and R

Vivienne van de Walle | Medical Director | P.T. and R » speaking at Drug Safety EU

Willemijn Van Der Spuij, Executive Director, International Patient Safety, Bristol-Myers Squibb

Willemijn Van Der Spuij | Executive Director, International Patient Safety | Bristol-Myers Squibb » speaking at Drug Safety EU

Lionel Van Holle, Founder, OpenSourcePV

Lionel Van Holle | Founder | OpenSourcePV » speaking at Drug Safety EU

Bert Van Leeuwen, Senior Director, Deputy QPPV, Astellas Pharma Europe BV

Mary Lynne van Poelgeest-Pomfret, President, World Federation for Incontinence and Pelvic Problems (WFIPP)

Mary Lynne van Poelgeest-Pomfret | President | World Federation for Incontinence and Pelvic Problems (WFIPP) » speaking at Drug Safety EU

Sarah Vaughan, Head of Vigilance Operations, MHRA

Sarah Vaughan | Head of Vigilance Operations | MHRA » speaking at Drug Safety EU

Deepa Venkataraman, Vice President, Head of Global Drug Safety and Pharmacovigilance, Corcept Therapeutics

Tommaso Venturi, Global Pharmacovigilance Risk Evaluation Specialist, ITALFARMACO S.P.A.

Tommaso Venturi | Global Pharmacovigilance Risk Evaluation Specialist | ITALFARMACO S.P.A. » speaking at Drug Safety EU

Jin Vermaat, Vice President, Head of PV Affiliate Relations, Takeda

Jin Vermaat | Vice President, Head of PV Affiliate Relations | Takeda » speaking at Drug Safety EU

Michael von Forstner, Head of Safety Science, Global Pharmacovigilance and Patient Safety, Sobi (Swedish Orphan Biovitrum)

Heike von Treichel, Senior Director, Deputy EU QPPV, Head of PV QMS and QPPV Office, Merck

Heike von Treichel | Senior Director, Deputy EU QPPV, Head of PV QMS and QPPV Office | Merck » speaking at Drug Safety EU

Ivana Vranic, Director, Safety Risk Lead, Inflammation & Immunology, Pfizer

Ivana Vranic | Director, Safety Risk Lead, Inflammation & Immunology | Pfizer » speaking at Drug Safety EU

Aman Wasan, Chief Executive Officer, ArisGlobal LLC

Aman Wasan | Chief Executive Officer | ArisGlobal LLC » speaking at Drug Safety EU

Rebecca Webb, Senior Director, Safety, Vigilance and Medical Affairs QA, AbbVie

Rebecca Webb | Senior Director, Safety, Vigilance and Medical Affairs QA | AbbVie » speaking at Drug Safety EU

James Whitehead, Senior Director, Devices and Digital Safety, Astra Zeneca

James Whitehead | Senior Director, Devices and Digital Safety | Astra Zeneca » speaking at Drug Safety EU

Rui Yang, Senior Medical Safety Director, Team Lead, Pharmacovigilance, Drug Safety, Genmab

Dilara Yuksel Gunbay, Associate Director, Patient Safety, AHoPS, Gilead Sciences

Dimitrios Zampatis, Global Program Safety Lead, Global Patient Safety, Sandoz

Dimitrios Zampatis | Global Program Safety Lead, Global Patient Safety | Sandoz » speaking at Drug Safety EU

Martine Zimmermann, Senior Vice President, Head of Regulatory, R&D Quality, Ipsen

Monika Zych, Director, Pharmacovigilance, Baxter

Get Involved At World Drug Safety Congress
 

Conference Production


George Mullens
george.mullens@terrapinn.com  
+44 20 8164 3940 

 

Sponsorship & Exhibition Sales


Rohit Dhap
rohit.dhap@terrapinn.com   
+44 20 8164 3001

 

Marketing Opportunities


Karen Duncan
karen.duncan@terrapinn.com